A10BD08 · Alimentary tract and metabolism
Icandra (previously Vildagliptin / metformin hydrochloride Novartis)
Indications
Icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus: in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4.4, 4.5 and 5.1 for available data on different combinations).
Composition
- Active substance
- vildagliptin, metformin hydrochloride
- International name (INN)
- vildagliptin;metformin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Icandra (previously Vildagliptin / metformin hydrochloride Novartis)
- Active substance
- vildagliptin, metformin hydrochloride